Investors

|

Portal
Order
Home / Research / Publications / Actionable Targets in Pancreatic Cancer Detected by Imunohistochemistry (IHC), Microarray (MA) Fluorescent in situ Hybridization (FISH) and Mutational Analysis

Innovation

Publications

Back

Actionable Targets in Pancreatic Cancer Detected by Imunohistochemistry (IHC), Microarray (MA) Fluorescent in situ Hybridization (FISH) and Mutational Analysis

– Caris Life Sciences

Poster

Background

A great need exists for new therapeutic approaches for patients with pancreatic cancer

Download Publication

Discover
More

  • Development and Validation of a Multimodal–Multitask Deep Learning Approach for Estimating Late Distant Recurrence Risk in HR-Positive Early Breast Cancer

    – Caris Life Sciences

    Manuscript

    Abstract Late distant recurrence (DR) remains a persistent risk in hormone receptor–positive (HR+) early breast cancer after completion of 5 years of endocrine therapy (ET).… […]

  • Proactive identification of candidates for newly approved targeted therapies using a clinical decision support program

    – Caris Life Sciences

    Manuscript

    Abstract Background Comprehensive molecular profiling (CMP) enables identification of multiple biomarkers from a single sample to inform targeted therapy selection. However, the static nature of… […]
Learn More

Ready to Get Started on the Journey?